Radiation therapy for oropharyngeal squamous cell carcinoma

  • Publication
    Online – April 2017
    Print – July 2017

    This guideline will focus on four critical topics facing radiation oncologists treating oropharyngeal cancer: the integration of concurrent chemotherapy with radiotherapy in the definitive and adjuvant settings, the indications for induction chemotherapy and the appropriate dose and fractionation regimens for treating the disease.

    Read executive summary

    Read full guideline

    Quick Reference

    • Concurrent therapy for high-risk patients
    • Optimal dosing and fractionation based on treatment approach
    • Risk of recurrence

    Reflections from the Patient Advocate
    Radiation therapy for Head and Neck Cancers
    The Management of Head and Neck Cancers

    Author Society
    American Society for Radiation Oncology

    Previous version

    European Society for Radiotherapy and Oncology (ESTRO)
    American Society of Clinical Oncology (ASCO)

  • Disclaimer

    ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.